Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.67 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.67 |
| ▸ | OSBP | P22059 | 1/20 | 0.67 |
| ▸ | RORC | P51449 | 1/20 | 0.67 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.67 |
| ▸ | POLA1 | P09884 | 1/20 | 0.63 |
| ▸ | GRIN1 | Q05586 | 12/20 | 0.61 |
| ▸ | GRIN2B | Q13224 | 12/20 | 0.61 |
| ▸ | GRIN2A | Q12879 | 10/20 | 0.61 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27963051 | 0.92 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL2638134 | 0.92 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL27963054 | 0.92 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL6060845 | 0.92 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL27975861 | 0.92 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL2637585 | 0.91 | USP2 (0.67) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL2221515 | 0.91 | USP2 (0.67) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL22194040 | 0.90 | USP2 (0.65) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL318120 | 0.90 | USP2 (0.65) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL22194041 | 0.90 | USP2 (0.65) | USP2CYP46A1LMNAABCB1OSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1179971-C | Adjuvent DC-chol, its liposome, preparation method and its use | 中国人民解放军第四五八医院 | 2004-12-15 | — | — | CN | claimed |
| CN-1442425-A | Adjuvent DC-chol, its liposome, preparation method and its use | NO 458 HOSPITAL PLA (CN) | 2003-09-17 | — | — | CN | claimed |
| EP-0748332-B1 | NEW CHOLESTEROL DERIVATIVE FOR LIPOSOMAL GENE TRANSFER | MAX DELBRUECK CENTRUM (DE) | 1999-11-10 | — | — | EP | claimed |
| US-5888821-A | ADMINISTERING DNA-LIPOSOME COMPLEXES | MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) | 1999-03-30 | — | — | US | claimed |
| CN-1179971-C | Adjuvent DC-chol, its liposome, preparation method and its use | 中国人民解放军第四五八医院 | 2004-12-15 | — | — | CN | disclosed |
| CN-1442425-A | Adjuvent DC-chol, its liposome, preparation method and its use | NO 458 HOSPITAL PLA (CN) | 2003-09-17 | — | — | CN | disclosed |
| EP-0748332-B1 | NEW CHOLESTEROL DERIVATIVE FOR LIPOSOMAL GENE TRANSFER | MAX DELBRUECK CENTRUM (DE) | 1999-11-10 | — | — | EP | disclosed |
| US-5888821-A | ADMINISTERING DNA-LIPOSOME COMPLEXES | MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) | 1999-03-30 | — | — | US | disclosed |
| US-5888821-A | ADMINISTERING DNA-LIPOSOME COMPLEXES | MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) | 1999-03-30 | — | — | US | disclosed |
| EP-0748332-A1 | NEW CHOLESTEROL DERIVATIVE FOR LIPOSOMAL GENE TRANSFER | MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) | 1996-12-18 | — | — | EP | disclosed |
| WO-1996020208-A3 | NEW CHOLESTEROL DERIVATIVE FOR LIPOSOMAL GENE TRANSFER | MAX DELBRUECK CENTRUM (DE) | 1996-09-06 | — | — | WO | disclosed |
| WO-1996020208-A2 | NEW CHOLESTEROL DERIVATIVE FOR LIPOSOMAL GENE TRANSFER | Max-Delbrück-Centrum für Molekulare Medizin (DE) | 1996-07-04 | — | — | WO | disclosed |